Pharma and Biotech
LTIP and DBP; Director/PDMR Notification | 12-Apr-2024 | 12:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 11-Apr-2024 | 16:00 | RNS |
Block Listing Interim Review | 08-Apr-2024 | 16:00 | RNS |
Issue of Equity and Total Voting Rights | 02-Apr-2024 | 14:00 | RNS |
Holding(s) in Company | 28-Mar-2024 | 17:55 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 12-Mar-2024 | 16:00 | RNS |
Director/PDMR Shareholding | 08-Mar-2024 | 12:00 | RNS |
Director/PDMR Shareholding | 07-Mar-2024 | 07:00 | RNS |
FY23 Preliminary Results | 06-Mar-2024 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 01-Mar-2024 | 14:00 | RNS |
Directorate Change | 29-Feb-2024 | 18:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 13-Feb-2024 | 16:00 | RNS |
Holding(s) in Company | 02-Feb-2024 | 16:30 | RNS |
Issue of Equity and Total Voting Rights | 01-Feb-2024 | 12:00 | RNS |
Expansion of leadership team | 22-Jan-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 92.75p |
Change Today | -1.75p |
% Change | -1.85 % |
52 Week High | 275.00p |
52 Week Low | 92.00p |
Volume | 631,136 |
Shares Issued | 859.96m |
Market Cap | £797.61m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 407,702 @ 92.75p |
16:35 | 905 @ 92.75p |
16:35 | 1,280 @ 92.75p |
16:35 | 1,035 @ 92.75p |
16:35 | 476 @ 92.75p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research